Vasiliki Pelekanou

Vasiliki Pelekanou

Bayer Crop Science - Missouri / United States
Medical and Health Sciences / Pathology
AD Scientific Index ID: 4400219
-
person_outline Vasiliki Pelekanou's MOST POPULAR ARTICLES
1-) Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung CancerJ McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...JAMA Oncology, 20157332015
2-) Immunological differences between primary and metastatic breast cancerB Szekely, V Bossuyt, X Li, VB Wali, GA Patwardhan, C Frederick, A Silber, ...Annals of Oncology 29 (11), 2232-2239, 20181982018
3-) Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1V Pelekanou, M Kampa, F Kiagiadaki, A Deli, P Theodoropoulos, ...Journal of Leucocyte Biology 99 (2), 333-347, 20161782016
4-) Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancerJA Rehman, G Han, DE Carvajal-Hausdorf, BE Wasserman, V Pelekanou, ...Modern Pathology 30 (3), 340-349, 20171762017
5-) Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological …VI Alexaki, G Notas, V Pelekanou, M Kampa, M Valkanou, ...The Journal of immunology 183 (9), 5948-5956, 20091302009